Ausgabe 3/2023
Inhalt (17 Artikel)
FlASHback—personal highlights regarding myelodysplastic syndrome from the 2022 ASH meeting
- Open Access
- short review
Verena Petzer, Dominik Wolf
ASH highlights 2022—multiple myeloma
- Open Access
- short review
Lina Z. Rüsing, Hermine Agis, Maria Krauth
New developments in radiation oncology for head and neck cancers
- Open Access
- short review
Christoph Resl, Petra Georg, Carmen Döller
Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma
- Open Access
- short review
Florian Kocher, Andreas Seeber
How the long-term follow-up is organized in young adult survivors of childhood cancer
- Open Access
- short review
Edit Bardi, Leo Kager, Wolfgang Holter
Next generation drugs in urothelial cancer: adenoviruses in the treatment of BCG-unresponsive nonmuscle invasive bladder cancer
- short review
Dominik A. Barth, Martin Pichler
Lipid nanoparticles in the treatment of lung cancer—hype or hope?
- Open Access
- short review
Anna Mair, Fabienne Nocera, Dominik Wolf, Andreas Pircher
Emerging molecular drugs for the treatment of gastroesophageal tumors
- Open Access
- leading article
Aysegül Ilhan-Mutlu
Assessment of nutritional status using objective and subjective methods in Greek patients with cancer
- Open Access
- original report
Konstantina Vamvakari, Iliana Evangelou, Ioanna Panagiota Kalafati, Michail Kipouros, Rena I. Kosti, Arezina N. Kasti, Odysseas Androutsos
Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin
- case report
Kaoutar Meliani, Noufissa Alami Dribi, Widad Rhandour, Afaf Amarti Riffi, Zineb Khammar, Rhyzlane Berrady
